AI assistant
VOLITIONRX LTD — Director's Dealing 2022
Aug 5, 2022
34395_dirs_2022-08-05_b3a432cb-c8b0-4a53-adb7-c38cab959a37.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2022-08-03-05:00
Reporting Person: TERRELL JASON BRADLEY MD (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-08-03-05:00 | Common Stock | F | 4279 | $1.97 | Disposed | 30866 | Direct |
| 2022-08-03-05:00 | Common Stock | F | 404 | $1.97 | Disposed | 2326 | Indirect |
Footnotes
F1: Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 17,573 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction.
F2: Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the spouse of the reporting person upon settlement of 1,365 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction.